Infectious Disease

Immunoglobulin therapy may play a role in treating COVID-19

June 06, 2022

1 minute watch

Source/Disclosures

sources:

Nath A, et al. Neuropsychiatric and neurological complications of COVID-19. Presented at: American Psychiatric Association annual meeting; May 21-25, 2022; New Orleans.

Disclosures:
Nath reports no relevant financial disclosures.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

NEW ORLEANS – Autopsy results in otherwise healthy people who died from COVID-19 suggest that immunoglobulin therapy may be an effective treatment choice, Avindra Nath, MD, said at the American Psychiatric Association annual meeting.

Findings from autopsies in these patients “suggest extensive glial cell activation, including infiltration of macrophages, that is probably the prime mediator of many of the [psychiatric symptoms],” Nath said.

A new NIH trial will evaluate the effect of high-dose corticosteroids and IV immunoglobulin on immune parameters, he said

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on . ” data-action=”subscribe”> Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

American Psychiatric Association Annual Meeting

Related Articles